BRITTANY BUSSEY: Open Payments
NPI 1639729064 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,721 in 121 payments from 19 companies in 2025. Trend: 2023 $918 · 2024 $2,459 · 2025 $2,721
Food & beverage: $2,622Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 24 | $602 |
| ABBVIE INC. | 32 | $535 |
| Teva Pharmaceuticals USA, Inc. | 8 | $288 |
| ACADIA Pharmaceuticals Inc | 14 | $256 |
| SK Life Science, Inc. | 7 | $156 |
| MDD US Operations, LLC | 5 | $110 |
| JAZZ PHARMACEUTICALS INC. | 3 | $104 |
| Neurelis, Inc. | 3 | $98 |
| Lundbeck LLC | 4 | $95 |
| Lilly USA, LLC | 4 | $86 |
Products named: Briviact, NUPLAZID, Fintepla, BOTOX, VYALEV, UBRELVY, AUSTEDO XR, EPIDIOLEX.
Industry payments across TX — which companies pay providers there.
